SION
NASDAQ · Biotechnology
Sionna Therapeutics Inc
$39.15
+0.45 (+1.16%)
Open$38.57
Previous Close$38.70
Day High$40.30
Day Low$38.07
52W High$46.46
52W Low$11.77
Volume—
Avg Volume407.0K
Market Cap1.95B
P/E Ratio—
EPS$-1.70
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-36.0% upside
Current
$39.15
$39.15
Target
$25.06
$25.06
$14.18
$25.06 avg
$26.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 242.99M | 245.23M | 253.21M |
| Net Income | -48,406,908 | -45,232,819 | -47,387,261 |
| Profit Margin | -19.9% | -18.5% | -18.7% |
| EBITDA | -47,660,000 | -53,758,331 | -46,826,478 |
| Free Cash Flow | -27,352,313 | -27,764,891 | -38,614,891 |
| Rev Growth | +24.0% | +24.2% | +22.9% |
| Debt/Equity | 0.34 | 0.34 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |